Keros Therapeutics, Inc.

NASDAQ
KROS
Stock
Yield per half year: +21.83%
Dividend yield: 0%
Sector: Healthcare
News
Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value - Keros Therapeutics ( NASDAQ:KROS ) , Takeda Pharmaceutical Co ( NYSE:TAK )

19 may 12:00 Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value - Keros Therapeutics ( NASDAQ:KROS ) , Takeda Pharmaceutical Co ( NYSE:TAK )